Paragraph 66 The Medicines for Human Use (Clinical Trials) Regulations 2004
(1)
The Medicines for Human Use (Clinical Trials) Regulations 2004 M1 are amended as follows.
(2)
In regulation 2(1) (interpretation), in the definition of “health service body”—
(a)
in paragraph (a), omit “Strategic Health Authority,”, and
(b)
in paragraph (b), omit “Primary Care Trust,”.
(3)
In Schedule 2 (additional provisions relating to ethics committees), in paragraph 3 (membership), after sub-paragraph (5) insert—
“(6)References in sub-paragraph (5) to a health service body include—
(a)a Strategic Health Authority,
(b)a Primary Care Trust,
(c)the National Institute for Health and Care Excellence, and
(d)the Health and Social Care Information Centre.”
Annotations
Marginal citations
- M1
S.I. 2004/1031. The relevant amending instrument is S.I. 2012/1641.